-
1
-
-
6444221460
-
Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group
-
Schwartz R.S., Edelman E.R., Carter A., Chronos N.A., Rogers C., Robinson K.A., Waksman R., Machan L., Weinberger J., Wilensky R.L., et al. Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation 110 (2004) 2498-2505
-
(2004)
Circulation
, vol.110
, pp. 2498-2505
-
-
Schwartz, R.S.1
Edelman, E.R.2
Carter, A.3
Chronos, N.A.4
Rogers, C.5
Robinson, K.A.6
Waksman, R.7
Machan, L.8
Weinberger, J.9
Wilensky, R.L.10
-
2
-
-
12144287135
-
Very long sirolimus-eluting stent implantation for de novo coronary lesions
-
Degertekin M., Arampatzis C.A., Lemos P.A., Saia F., Hoye A., Daemen J., Tanabe K., Lee C.H., Hofma S.J., Sianos G., et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol 93 (2004) 826-829
-
(2004)
Am J Cardiol
, vol.93
, pp. 826-829
-
-
Degertekin, M.1
Arampatzis, C.A.2
Lemos, P.A.3
Saia, F.4
Hoye, A.5
Daemen, J.6
Tanabe, K.7
Lee, C.H.8
Hofma, S.J.9
Sianos, G.10
-
3
-
-
27744451988
-
"Full metal jacket" (stented length > or = 64 mm) using drug-eluting stents for de novo coronary artery lesions
-
Aoki J., Ong A.T., Rodriguez Granillo G.A., McFadden E.P., van Mieghem C.A., Valgimigli M., Tsuchida K., Sianos G., Regar E., de Jaegere P.P., et al. "Full metal jacket" (stented length > or = 64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 150 (2005) 994-999
-
(2005)
Am Heart J
, vol.150
, pp. 994-999
-
-
Aoki, J.1
Ong, A.T.2
Rodriguez Granillo, G.A.3
McFadden, E.P.4
van Mieghem, C.A.5
Valgimigli, M.6
Tsuchida, K.7
Sianos, G.8
Regar, E.9
de Jaegere, P.P.10
-
4
-
-
21044454746
-
Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery
-
Tsagalou E., Chieffo A., Iakovou I., Ge L., Sangiorgi G.M., Corvaja N., Airoldi F., Montorfano M., Michev I., and Colombo A. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 45 (2005) 1570-1573
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1570-1573
-
-
Tsagalou, E.1
Chieffo, A.2
Iakovou, I.3
Ge, L.4
Sangiorgi, G.M.5
Corvaja, N.6
Airoldi, F.7
Montorfano, M.8
Michev, I.9
Colombo, A.10
-
5
-
-
0002418650
-
Qualitative and quantitative angiography
-
Topol E. (Ed), WB Saunders, Philadelphia
-
Popma J.J., and Bashore T.D. Qualitative and quantitative angiography. In: Topol E. (Ed). Textbook of Interventional Cardiology (1994), WB Saunders, Philadelphia 1052-1068
-
(1994)
Textbook of Interventional Cardiology
, pp. 1052-1068
-
-
Popma, J.J.1
Bashore, T.D.2
-
6
-
-
22144474043
-
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents
-
Finn A.V., Kolodgie F.D., Harnek J., Guerrero L.J., Acampado E., Tefera K., Skorija K., Weber D.K., Gold H.K., and Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
-
(2005)
Circulation
, vol.112
, pp. 270-278
-
-
Finn, A.V.1
Kolodgie, F.D.2
Harnek, J.3
Guerrero, L.J.4
Acampado, E.5
Tefera, K.6
Skorija, K.7
Weber, D.K.8
Gold, H.K.9
Virmani, R.10
-
7
-
-
23844482954
-
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization
-
Windecker S., Remondino A., Eberli F.R., Juni P., Raber L., Wenaweser P., Togni M., Billinger M., Tuller D., Seiler C., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
-
(2005)
N Engl J Med
, vol.353
, pp. 653-662
-
-
Windecker, S.1
Remondino, A.2
Eberli, F.R.3
Juni, P.4
Raber, L.5
Wenaweser, P.6
Togni, M.7
Billinger, M.8
Tuller, D.9
Seiler, C.10
-
8
-
-
23844538250
-
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients
-
ISAR-DIABETES Study Investigators
-
Dibra A., Kastrati A., Mehilli J., Pache J., Schuhlen H., von Beckerath N., Ulm K., Wessely R., Dirschinger J., Schomig A., and ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
-
(2005)
N Engl J Med
, vol.353
, pp. 663-670
-
-
Dibra, A.1
Kastrati, A.2
Mehilli, J.3
Pache, J.4
Schuhlen, H.5
von Beckerath, N.6
Ulm, K.7
Wessely, R.8
Dirschinger, J.9
Schomig, A.10
-
9
-
-
33751328285
-
Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients
-
Biondi-Zoccai G.G., Lotrionte M., Abbate A., Valgimigli M., Testa L., Burzotta F., Crea F., and Agostoni P. Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients. Int J Cardiol 114 (2007) 104-105
-
(2007)
Int J Cardiol
, vol.114
, pp. 104-105
-
-
Biondi-Zoccai, G.G.1
Lotrionte, M.2
Abbate, A.3
Valgimigli, M.4
Testa, L.5
Burzotta, F.6
Crea, F.7
Agostoni, P.8
-
10
-
-
6044259204
-
Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells
-
Mondesire W.H., Jian W., Zhang H., Ensor J., Hung M.C., Mills G.B., and Meric-Bernstam F. Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells. Clin Cancer Res 10 (2004) 7031-7042
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7031-7042
-
-
Mondesire, W.H.1
Jian, W.2
Zhang, H.3
Ensor, J.4
Hung, M.C.5
Mills, G.B.6
Meric-Bernstam, F.7
|